These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 25209307)

  • 1. Medication adherence and resistant hypertension.
    Hyman DJ; Pavlik V
    J Hum Hypertens; 2015 Apr; 29(4):213-8. PubMed ID: 25209307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summary and Conclusions.
    Bakris G
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S23. PubMed ID: 26149526
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing 'resistance': is adherence a target for treatment?
    Burnier M
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):439-43. PubMed ID: 25036746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redefining Resistant Hypertension: A Comparison of Cardiovascular Risk Associated With the 2018 Versus 2008 American Heart Association Definitions for Resistant Hypertension.
    Smith SM; Gurka MJ; Winterstein AG; Handberg E; Pepine CJ; Cooper-DeHoff RM
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e005979. PubMed ID: 32008359
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy.
    Waeber B; Feihl F
    EuroIntervention; 2013 May; 9 Suppl R():R29-34. PubMed ID: 23732152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation.
    Patel P; Gupta PK; White CM; Stanley AG; Williams B; Tomaszewski M
    J Hum Hypertens; 2016 Jun; 30(6):368-73. PubMed ID: 26446393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
    Kjeldsen SE; Os I; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic Drug Monitoring to Assess Drug Adherence in Assumed Resistant Hypertension: A Comparison With Directly Observed Therapy in Three Nonadherent Patients.
    Šíma M; Slanař O
    J Cardiovasc Pharmacol; 2019 Feb; 73(2):125. PubMed ID: 30531438
    [No Abstract]   [Full Text] [Related]  

  • 9. Highlights of ESC/ESH 2018 Guidelines on the Management of Hypertension: What Every Doctor Should Know.
    Volpe M; Gallo G; Battistoni A; Tocci G
    High Blood Press Cardiovasc Prev; 2019 Feb; 26(1):1-8. PubMed ID: 30604199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to antihypertensive therapy and therapeutic dosage of antihypertensive drugs.
    Rabbia F; Fulcheri C; Di Monaco S; Covella M; Perlo E; Pappaccogli M; Veglio F
    High Blood Press Cardiovasc Prev; 2016 Dec; 23(4):341-345. PubMed ID: 27160721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different strategies from monotherapies to dual or triple fixed dose combination therapies to achieve blood pressure goals: a summary of a satellite symposium from the European Society of Hypertension, June 13-16, 2014 Athens, Greece. Introduction.
    Redon J
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S3-4. PubMed ID: 25929685
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistant Hypertension: An Incurable Disease or Just a Challenge For Our Medical Skill?
    Di Pilla M; Bruno RM; Taddei S
    High Blood Press Cardiovasc Prev; 2016 Dec; 23(4):347-353. PubMed ID: 27188195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A global approach to hypertension.
    van den Meiracker AH
    EuroIntervention; 2013 May; 9 Suppl R():R16-20. PubMed ID: 23732150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving Goal Blood Pressure.
    Laurent S
    High Blood Press Cardiovasc Prev; 2015 Jul; 22 Suppl 1():S5-9. PubMed ID: 26002423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical appraisal of the guidelines from France, the UK, Europe and the USA for the management of hypertension in adults.
    Stephan D; Gaertner S; Cordeanu EM
    Arch Cardiovasc Dis; 2015; 108(8-9):453-9. PubMed ID: 26113481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension: Overly important but under-controlled.
    van Kleef ME; Spiering W
    Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):36-43. PubMed ID: 28618912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to antihypertensive therapy affects Ambulatory Arterial Stiffness Index.
    Berni A; Ciani E; Cecioni I; Poggesi L; Abbate R; Boddi M
    Eur J Intern Med; 2011 Feb; 22(1):93-8. PubMed ID: 21238902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to medication and drug monitoring in apparent treatment-resistant hypertension.
    Eskås PA; Heimark S; Eek Mariampillai J; Larstorp AC; Fadl Elmula FE; Høieggen A
    Blood Press; 2016 Aug; 25(4):199-205. PubMed ID: 26729283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How can resistant hypertension be identified and prevented?
    Solini A; Ruilope LM
    Nat Rev Cardiol; 2013 May; 10(5):293-6. PubMed ID: 23459606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence in Hypertension.
    Burnier M; Egan BM
    Circ Res; 2019 Mar; 124(7):1124-1140. PubMed ID: 30920917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.